Background There are 15· 4 million children who are HIV-exposed and uninfected
worldwide. Early child development crucially influences later academic and socioeconomic …

Prior to widespread availability of antiretroviral therapy (ART) in sub-Saharan Africa,
children who were HIV-exposed but uninfected (HEU) had increased mortality, morbidity …

Background: With the growing population of HIV-exposed uninfected (HEU) children
globally, it is important to determine population-level growth differences between HEU and …

Introduction Studies have reported a higher risk of suboptimal neurodevelopment among
children who are HIV‐exposed uninfected (HEU) compared to children HIV‐unexposed …

Simple Summary Although the use of antiretroviral treatment (ART) is effective in reducing
the risk of HIV transmission to the foetus, there are concerns of possible adverse effects of in …

Background: Perinatal HIV and antiretroviral therapy exposure may influence neurocognitive
outcomes, although evidence is mixed and most studies are limited to outcomes in the first …

Few studies have compared clinical outcomes in HIV-exposed uninfected (HEU) and HIV-
unexposed uninfected (HUU) infants in the current scenario of universal and lifelong …

Objective: To compare childhood physical growth among antiretroviral drug and maternal
HIV-exposed uninfected (AHEU) compared with HIV-unexposed uninfected (HUU) children …

Background There is a growing population of children with in utero HIV exposure who are at
risk of poor neurodevelopmental outcomes despite avoiding HIV infection. However, the …

Background: HIV-exposed but uninfected (HEU) infants are at increased risk of impaired
early linear growth and cognitive development. We examined associations between …